Auristatin E |
Catalog No.GC35429 |
La auristatina E es un modificador de tubulina citotÓxico con actividad antitumoral potente y selectiva; AnÁlogo de MMAE y citotoxina en conjugados de fÁrmaco-anticuerpo. La auristatina E inhibe la divisiÓn celular al bloquear la polimerizaciÓn de la tubulina.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 160800-57-7
Sample solution is provided at 25 µL, 10mM.
Auristatin E is a cytotoxic tubulin modifier with potent and selective antitumor activity; MMAE analog and cytotoxin in Antibody-drug conjugates.
[1]. Francisco JA, et al. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood. 2003 Aug 15;102(4):1458-65. [2]. Li D, et al. DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma. Mol Cancer Ther. 2013 Jul;12(7):1255-65.
Average Rating: 5
(Based on Reviews and 11 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *